|
|
|
|
|
|
|
Table 20. Reported cases of HIV infection (not AIDS) for male adults and adolescents, by transmission category and race/ethnicity, 2006 and cumulative—45 states and
5 U.S. dependent areas with confidential name-based HIV infection reporting |
|
|
View PDF
|
|
|
|
|
|
|
|
|
2006 |
|
Cumulativea |
Transmission category |
No. |
% |
|
No. |
% |
|
White, not Hispanic |
Male-to-male sexual contact |
11,963 |
73 |
|
55,725 |
69 |
Injection drug use |
858 |
5 |
|
5,512 |
7 |
Male-to-male sexual contact and injection drug use |
1,092 |
7 |
|
5,578 |
7 |
Hemophilia/coagulation disorder |
29 |
0 |
|
355 |
0 |
High-risk heterosexual contactb |
522 |
3 |
|
2,658 |
3 |
Sex with injection drug user |
65 |
0 |
|
544 |
1 |
Sex with person with hemophilia |
0 |
0 |
|
8 |
0 |
Sex with HIV-infected transfusion recipient |
3 |
0 |
|
33 |
0 |
Sex with HIV-infected person, risk factor not specified |
454 |
3 |
|
2,073 |
3 |
Receipt of blood transfusion, blood components, or tissue |
14 |
0 |
|
197 |
0 |
Other/risk factor not reported or identified |
1,956 |
12 |
|
11,147 |
14 |
Total |
16,434 |
100 |
|
81,172 |
100 |
|
|
|
Black, not Hispanic |
Male-to-male sexual contact |
6,203 |
44 |
|
30,148 |
37 |
Injection drug use |
1,594 |
11 |
|
11,997 |
15 |
Male-to-male sexual contact and injection drug use |
483 |
3 |
|
3,489 |
4 |
Hemophilia/coagulation disorder |
10 |
0 |
|
109 |
0 |
High-risk heterosexual contactb |
1,714 |
12 |
|
10,905 |
13 |
Sex with injection drug user |
169 |
1 |
|
1,554 |
2 |
Sex with person with hemophilia |
4 |
0 |
|
17 |
0 |
Sex with HIV-infected transfusion recipient |
6 |
0 |
|
77 |
0 |
Sex with HIV-infected person, risk factor not specified |
1,535 |
11 |
|
9,257 |
11 |
Receipt of blood transfusion, blood components, or tissue |
32 |
0 |
|
223 |
0 |
Other/risk factor not reported or identified |
4,151 |
29 |
|
24,632 |
30 |
Total |
14,187 |
100 |
|
81,503 |
100 |
|
|
|
Hispanic |
Male-to-male sexual contact |
4,094 |
55 |
|
15,623 |
47 |
Injection drug use |
993 |
13 |
|
6,407 |
19 |
Male-to-male sexual contact and injection drug use |
316 |
4 |
|
1,402 |
4 |
Hemophilia/coagulation disorder |
3 |
0 |
|
26 |
0 |
High-risk heterosexual contactb |
582 |
8 |
|
2,963 |
9 |
Sex with injection drug user |
65 |
1 |
|
455 |
1 |
Sex with person with hemophilia |
0 |
0 |
|
6 |
0 |
Sex with HIV-infected transfusion recipient |
4 |
0 |
|
18 |
0 |
Sex with HIV-infected person, risk factor not specified |
513 |
7 |
|
2,484 |
7 |
Receipt of blood transfusion, blood components, or tissue |
11 |
0 |
|
55 |
0 |
Other/risk factor not reported or identified |
1,475 |
20 |
|
6,977 |
21 |
Total |
7,474 |
100 |
|
33,453 |
100 |
|
|
|
Asian/Pacific Islander |
Male-to-male sexual contact |
402 |
70 |
|
1,006 |
63 |
Injection drug use |
17 |
3 |
|
55 |
3 |
Male-to-male sexual contact and injection drug use |
15 |
3 |
|
38 |
2 |
Hemophilia/coagulation disorder |
0 |
0 |
|
1 |
0 |
High-risk heterosexual contactb |
25 |
4 |
|
96 |
6 |
Sex with injection drug user |
3 |
1 |
|
10 |
1 |
Sex with person with hemophilia |
0 |
0 |
|
0 |
0 |
Sex with HIV-infected transfusion recipient |
0 |
0 |
|
3 |
0 |
Sex with HIV-infected person, risk factor not specified |
22 |
4 |
|
83 |
5 |
Receipt of blood transfusion, blood components, or tissue |
4 |
1 |
|
7 |
0 |
Other/risk factor not reported or identified |
109 |
19 |
|
397 |
25 |
Total |
572 |
100 |
|
1,600 |
100 |
|
|
|
American Indian/Alaska Native |
Male-to-male sexual contact |
104 |
61 |
|
516 |
57 |
Injection drug use |
13 |
8 |
|
101 |
11 |
Male-to-male sexual contact and injection drug use |
19 |
11 |
|
110 |
12 |
Hemophilia/coagulation disorder |
0 |
0 |
|
0 |
0 |
High-risk heterosexual contactb |
10 |
6 |
|
53 |
6 |
Sex with injection drug user |
2 |
1 |
|
14 |
2 |
Sex with person with hemophilia |
0 |
0 |
|
0 |
0 |
Sex with HIV-infected transfusion recipient |
0 |
0 |
|
0 |
0 |
Sex with HIV-infected person, risk factor not specified |
8 |
5 |
|
39 |
4 |
Receipt of blood transfusion, blood components, or tissue |
0 |
0 |
|
2 |
0 |
Other/risk factor not reported or identified |
24 |
14 |
|
125 |
14 |
Total |
170 |
100 |
|
907 |
100 |
|
|
|
Total cases |
Male-to-male sexual contact |
22,912 |
59 |
|
103,679 |
52 |
Injection drug use |
3,503 |
9 |
|
24,255 |
12 |
Male-to-male sexual contact and injection drug use |
1,946 |
5 |
|
10,704 |
5 |
Hemophilia/coagulation disorder |
43 |
0 |
|
495 |
0 |
High-risk heterosexual contactb |
2,874 |
7 |
|
16,830 |
8 |
Sex with injection drug user |
308 |
1 |
|
2,601 |
1 |
Sex with person with hemophilia |
4 |
0 |
|
31 |
0 |
Sex with HIV-infected transfusion recipient |
13 |
0 |
|
131 |
0 |
Sex with HIV-infected person, risk factor not specified |
2,549 |
7 |
|
14,067 |
7 |
Receipt of blood transfusion, blood components, or tissue |
61 |
0 |
|
489 |
0 |
Other/risk factor not reported or identified |
7,748 |
20 |
|
44,021 |
22 |
Total |
39,087c |
100 |
|
200,473d |
100 |
|
|
|
Note. See
Table 16 for list of 45 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting as of December 2006. |
a |
From the beginning of the epidemic through December 2006. |
b |
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. |
c |
Includes 250 males of unknown race or multiple races. |
d |
Includes 1,838 males of unknown race or multiple races. |
|
Next: Table 21 |
|
|
|
|
|
|
|
|